Cargando…
What Are the bona fide GSK3 Substrates?
Nearly 100 proteins are proposed to be substrates for GSK3, suggesting that this enzyme is a fundamental regulator of almost every process in the cell, in every tissue in the body. However, it is not certain how many of these proposed substrates are regulated by GSK3 in vivo. Clearly, the identifica...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100594/ https://www.ncbi.nlm.nih.gov/pubmed/21629754 http://dx.doi.org/10.4061/2011/505607 |
_version_ | 1782204201577742336 |
---|---|
author | Sutherland, Calum |
author_facet | Sutherland, Calum |
author_sort | Sutherland, Calum |
collection | PubMed |
description | Nearly 100 proteins are proposed to be substrates for GSK3, suggesting that this enzyme is a fundamental regulator of almost every process in the cell, in every tissue in the body. However, it is not certain how many of these proposed substrates are regulated by GSK3 in vivo. Clearly, the identification of the physiological functions of GSK3 will be greatly aided by the identification of its bona fide substrates, and the development of GSK3 as a therapeutic target will be highly influenced by this range of actions, hence the need to accurately establish true GSK3 substrates in cells. In this paper the evidence that proposed GSK3 substrates are likely to be physiological targets is assessed, highlighting the key cellular processes that could be modulated by GSK3 activity and inhibition. |
format | Text |
id | pubmed-3100594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | SAGE-Hindawi Access to Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-31005942011-05-31 What Are the bona fide GSK3 Substrates? Sutherland, Calum Int J Alzheimers Dis Review Article Nearly 100 proteins are proposed to be substrates for GSK3, suggesting that this enzyme is a fundamental regulator of almost every process in the cell, in every tissue in the body. However, it is not certain how many of these proposed substrates are regulated by GSK3 in vivo. Clearly, the identification of the physiological functions of GSK3 will be greatly aided by the identification of its bona fide substrates, and the development of GSK3 as a therapeutic target will be highly influenced by this range of actions, hence the need to accurately establish true GSK3 substrates in cells. In this paper the evidence that proposed GSK3 substrates are likely to be physiological targets is assessed, highlighting the key cellular processes that could be modulated by GSK3 activity and inhibition. SAGE-Hindawi Access to Research 2011-05-18 /pmc/articles/PMC3100594/ /pubmed/21629754 http://dx.doi.org/10.4061/2011/505607 Text en Copyright © 2011 Calum Sutherland. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Sutherland, Calum What Are the bona fide GSK3 Substrates? |
title | What Are the bona fide GSK3 Substrates? |
title_full | What Are the bona fide GSK3 Substrates? |
title_fullStr | What Are the bona fide GSK3 Substrates? |
title_full_unstemmed | What Are the bona fide GSK3 Substrates? |
title_short | What Are the bona fide GSK3 Substrates? |
title_sort | what are the bona fide gsk3 substrates? |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100594/ https://www.ncbi.nlm.nih.gov/pubmed/21629754 http://dx.doi.org/10.4061/2011/505607 |
work_keys_str_mv | AT sutherlandcalum whatarethebonafidegsk3substrates |